[1]茅青, 贾宪生. 黄褐毛忍冬化学成分的研究\[J\]. 药学学报, 1989, 24(4):269-274.
[2]汤丹, 李会军, 钱正明, 等. 黄褐毛忍冬花蕾咖啡酰奎宁酸类成分研究\[J\].中国药学杂志, 2007, 42(20): 1537-1539.
[3]Wang X, Wei Y, Tian WY, et al.Characterization of nine compounds isolated from the acid hydrolysate of Lonicera fulvotomentosa Hsu et S. C. Cheng and evaluation of their in vitro activity towards HIV protease\[J\].Molecules,2019, 24(24):4526.
[4]杨兰,刘东波,舒利,等. 不同基源“金银花”的功能和应用研究进展\[J\].食品与机械,2020,36(1):10-19.
[5]汤瑾,刘文,苏松柏,等.金银花、山银花不同提取物对小鼠化学性肝损伤的保护作用研究\[J\].亚太传统医药,2016,12(16):9-11.
[6]Liu MH, Tong X, Wang JX, et al. Rapid separation and identification of multiple constituents in traditionalChinese medicine formula Shenqi Fuzheng Injection by ultrafast liquid chromatography combined with quadrupoletimeof flight mass spectrometry\[J\]. J Pharm Biomed Anal, 2013, 74(4): 141-155.
[7]杨岱琳, 佟玲, 李晓稳, 等. UPLCQTOF/MSE 方法分析养血清脑颗粒的化学成分\[J\]. 药学学报, 2016,51(5): 797-805.
[8]Ma YM, Zhang XZ, Su ZZ, et al. Insight into the molecular mechanism of a herbal injection by integrating network pharmacology and in vitro\[J\]. J Ethnopharmacol, 2015,173:91-99.
[9]Bai G, Hou YY, Jiang M, et al. Integrated systems biology and chemical biology approach to exploring mechanisms of traditional Chinese medicines\[J\]. Chin Herb Med, 2016, 8(2): 99-106.
[10]Gimenez BG,Santos MS,Ferrarini M,et al.Evaluation of blockbuster drugs under the ruleoffive\[J\].Pharmazie,2010,65(2):148-152.
[11]Lipinski CA. Rule of five in 2015 and beyond:target and ligand structural limitations,ligand chemistry structure and drug discovery project decisions\[J\]. Adv Drug Deliver Rev,2016,101:34-41.
[12]张伟贤,兰天,董嘉乐,等.山柰酚抵抗对乙酰氨基酚引起的肝细胞损伤研究\[J\].世界中医药, 2019,14(1):39-43.
[13]Lee SH, Kim B, Oh MJ, et al. Persicaria hydropiper (L.) spach and its flavonoid components, isoquercitrin and isorhamnetin, activatethe Wnt/βcatenin pathway and inhibit adipocyte differentiation of 3T3L1 cells\[J\]. Phytother Res, 2011,25:1629-1635.
[14]Zhou JX, Yoshitomi H, Liu TH, et al. Isoquercitrin activates the AMPactivated protein kinase (AMPK) signal pathway in rat H4IIE cells\[J\]. BMC Complement Altern Med, 2014, 14:42.
[15]王秀芳,晏春根.木犀草苷对小鼠非酒精性脂肪肝病的作用研究\[J\].中华全科医学, 2019,17 (1):21-24,51.
[16]延华, 张颖, 王欢,等. 绿原酸抑制JNK 信号通路对非酒精性脂肪性肝病的防治作用\[J\].临床肝胆病杂志,2018,34 (2):359-363.
[17]Kuo WH,Yang SF,Hsieh YS, et al. Differential expression of carbonic anhydrase isoenzymes in various types of anemia\[J\].Clin Chim Acta, 2005, 351(1-2): 79-86.
[18]Neumeier M,Weigert J,Schafflerr A, et al.Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro\[J\]. Biochem Biophys Res Commun,2006,350(3): 731-735.
[19]Wang XF, Zhang X, Wang F, et al. FGF1 protects against APAPinduced hepatotoxicity via suppression of oxidative and endoplasmic reticulum stress\[J\].Clin Res Hepatol Gastroenterol, 2019,43(6):707-714.
[20]Wu S, Zhang W, Ma S, et al.ERK1/2 and JNK signaling synergistically modulate mitogenic effect of fibroblast growth factor 2 on liver cell\[J\].Cell Biol Int, 2018, 42(11):1511-1522.
[21]金立方,倪坚,闫俊艳,等.Hedgehog信号通路对肝脏损伤修复作用的研究进展\[J\].中国细胞生物学学报, 2019, 41(8): 1615-1621.
[22]张祎婕,肖俊丽,张小燕, 等.肝纤维化过程中HIPPO信号通路调控机制的研究进展\[J\].华中科技大学学报(医学版),2019, 48(3):350-354.
[23]Khalaf AM,Fuentes D,Morshid AI,et al. Role of wnt/βcatenin signaling in hepatocellular carcinoma,pathogenesis, and clinical significance\[J\]. J Hepatocell Carcinoma,2018,5:61-73.
[24]Liu LJ,Xie SX,Chen YT,et al. Aberrant regulation of wnt signaling in hepatocellular carcinoma\[J\]. World J Gastroenterol,2016,22(33):7486-7499.
[25]Katoh M. Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical wnt/βcatenin signaling activation\[J\].Int J Mol Med,2018, 42(2):713-725.
[26]张剑,李作标,李嘉兴,等.Wnt/βcatenin信号通路与肝脏疾病相关性的研究进展\[J\].实用医学杂志, 2019,35(14):2347-2351. |